Federated Hermes, Inc. Immuneering Corp Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Immuneering Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,838 shares of IMRX stock, worth $7,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,838
Previous 5,135
25.26%
Holding current value
$7,215
Previous $12,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMRX
# of Institutions
42Shares Held
4.68MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.99 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD767KShares$1.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$844,7040.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$462,9870.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $49.6M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...